cyclosporine has been researched along with Autoimmune Diabetes in 209 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.96) | 18.7374 |
| 1990's | 134 (64.11) | 18.2507 |
| 2000's | 51 (24.40) | 29.6817 |
| 2010's | 20 (9.57) | 24.3611 |
| 2020's | 2 (0.96) | 2.80 |
| Authors | Studies |
|---|---|
| Han, DJ; Jung, CH; Jung, JH; Kim, DH; Kim, YH; Ko, Y; Kwon, H; Lim, SJ; Mun, S; Shin, S | 1 |
| Babushok, DV; Duke, JL; Huang, Y; Monos, DS; Olson, TS; Oved, JH; Stanley, N; Teachey, DT | 1 |
| Geng, S; Wang, B; Wang, XY; Yu, F; Yu, W; Zhang, S; Zhao, G; Zhou, X | 1 |
| Chinnakotla, S; Dunn, TB; Finger, EB; Gillingham, KJ; Kandaswamy, R; Matas, AJ; Najarian, JS; Payne, WD; Pruett, TL; Rizzari, MD; Suszynski, TM; Sutherland, DER | 1 |
| Jovanovic, L; Levetan, C; Pozzilli, P; Schatz, D | 1 |
| Hirakata, A; Hong, H; Okumi, M; Sachs, DH; Shimizu, A; Tchipashvili, V; Vallabhajosyula, P; Yamada, K | 1 |
| Calzavara-Pinton, P; Farisoglio, C; Gualdi, G; Monari, P | 1 |
| Augustson, B; Hessamodini, H; Lim, WH; Viecelli, A | 1 |
| Collardeau-Frachon, S; Duclaux-Loras, R; Fabien, N; Kaiserlian, D; Lachaux, A; Nancey, S | 1 |
| Alihemmati, A; Azimi, A; Badalzadeh, R; Yousefi, B | 1 |
| Coelho, R; Flagg, A; Gonzalez, BE; Hanna, R; Harrington, S; Kusick, K; Ondrejka, S; Procop, GW; Stempak, LM; Zembillas, A | 1 |
| Cuervas-Mons, V; D'Avola, D; Fábrega, E; Fraga, E; Gómez, MA; Herrero, JI; Jimenez, C; Lladó, L; Lopez, P; Martí, J; Ortiz de Urbina, J; Otero, E; Rios, A; Rodrigo, JM; Serrano, MT; Suarez, F | 1 |
| Cibrik, DM; Lake, KD; Park, JM | 1 |
| Ansite, JD; Balamurugan, AN; Bansal-Pakala, P; Bellin, MD; Hering, BJ; Ihm, SH; Kandaswamy, R; Liu, B; Moran, A; Papas, K; Papas, KK; Parkey, J; Sutherland, DE; Witson, J; Zhang, HJ | 1 |
| Edgar, RL; Emamaullee, J; Merani, S; Shapiro, AM; Thiesen, A; Toso, C | 1 |
| Audrain, M; Hamidou, MA; Hervier, B; Masseau, A; Mussini, JM | 1 |
| Abbassi, V; Henzke, A; Sobel, DO | 1 |
| Chen, Y; Dorn, GW; Fujimoto, K; Polonsky, KS | 1 |
| Brendel, MD; Bretzel, RG; Burkart, V; Eckhard, M; Hogenkamp, V; Jaeger, C; Pfleger, C; Schloot, NC | 1 |
| Bach, JF; Chatenoud, L | 1 |
| Kanekura, T; Kawai, K; Sakanoue, M | 1 |
| DeWeerdt, S | 1 |
| Gupta, S | 1 |
| Baeke, F; Ding, L; Gysemans, C; Korf, H; Laureys, J; Mathieu, C; Takiishi, T; Van Belle, TL | 1 |
| Korsgren, O; Tufveson, G; von Zur-Mühlen, B | 1 |
| Skyler, JS | 1 |
| Bechstein, WO; Dette, K; Lübke, P; Pridöhl, O; Woeste, G; Wullstein, C | 1 |
| Hering, BJ; Wijkstrom, M | 1 |
| Daudén, E; García-Díez, A | 1 |
| Büsing, M; Heimes, M; Schindler, A; Schulz, T | 1 |
| Henderson, JD; Lai, CS; Pieper, GM; Roza, AM | 1 |
| Fajardy, I; Gmyr, V; Kerr-Conte, J; Noel, C; Pattou, F; Pigny, P; Proye, C; Vandewalle, B; Vantyghem, MC | 1 |
| Balshaw, R; Heisel, O; Heisel, R; Keown, P | 1 |
| Malaise, J; Squifflet, JP; Van Ophem, D | 1 |
| Inoue, S; Ishibashi, M; Ito, T; Kanazawa, Y; Matsuno, N; Motoyama, K; Nakajima, K; Ota, M; Sugitani, A; Tanaka, M; Yamamoto, H; Yoshida, JI | 1 |
| Bechstein, WO; Berney, T; Boucek, P; Fernandez-Cruz, L; Kahl, A; Land, W; Landgraf, R; Malaise, J; Margreiter, R; Nakache, R; Saudek, F; Secchi, A; Squifflet, JP; Tydén, G; Van Ophem, D; Vanrenterghem, Y | 1 |
| Dumont, FJ | 1 |
| Dieterle, CD; Gutt, B; Illner, WD; Land, W; Landgraf, R; Schmauss, S; Veitenhansl, M | 1 |
| Biesenbach, G; Janko, O; Schmekal, B | 1 |
| Arbogast, H; Dieterle, C; Illner, WD; Land, W; Landgraf, R; Malaise, J; Tarabichi, A | 1 |
| Adamec, M; Boucek, P; Malaise, J; Saudek, F | 1 |
| Claes, K; Coosemans, W; Evenepoel, P; Kuypers, DR; Maes, B; Malaise, J; Pirenne, J; Vanrenterghem, Y | 1 |
| Malaise, J; Nakache, R; Van Ophem, D | 1 |
| Koenigsrainer, A; Malaise, J; Margreiter, R; Mark, W; Steurer, W | 1 |
| Bernazzali, S; Berti, L; Chiavarelli, M; Diciolla, F; Federici, D; Lisi, G; Maccherini, M; Scolletta, S | 1 |
| Blancho, G; Cantarovich, D; Dantal, J; Giral, M; Hourmant, M; Karam, G; Soulillou, JP | 1 |
| Bernard, S; Boillot, O; Bouffard, Y; Dumortier, J | 1 |
| Drewelow, B; Gock, M; Klar, E; Kundt, G; Schareck, W; Wacke, R | 1 |
| Byun, Y; Hee Nam, J; Yun Lee, D | 1 |
| Imes, S; Kin, T; Kneteman, NM; Korbutt, GS; Lakey, JR; Rajotte, RV; Ryan, EA; Shapiro, AM; Tsapogas, P; Warnock, GL | 1 |
| Gruessner, AC; Gruessner, RW; Kandaswamy, R; Sutherland, DE | 1 |
| De Santis, M; Ferraccioli, G; Gremese, E | 1 |
| Abe, M; Akamatsu, M; Babazono, T; Haruguchi, H; Hirotani, S; Kimikawa, M; Kitajima, K; Koike, T; Shinkai, M; Teraoka, S | 1 |
| Fioretto, P; Mauer, M; Mihatsch, MJ; Steffes, MW; Strøm, EH; Sutherland, DE | 1 |
| Breckenridge, C; Gault, MH; Harnett, J; Longerich, LL; Purchase, L | 1 |
| Bromberg, JS; Campbell, DA; Merion, RM; Punch, JD; Shieck, VL; Turcotte, JG | 1 |
| Djordjević, P; Dragasević, M; Kalimanovska, V; Lalić, N; Savić, K; Vujosević, S; Zamaklar, M | 1 |
| Bach, JF; Boitard, C; Chatenoud, L; Timsit, J; Volpini, W | 1 |
| Abu-Elmagd, K; Carroll, PB; McCauley, J; Starzl, TE; Thomson, AW; Van Thiel, DH; Woo, J | 1 |
| Benfield, P; Faulds, D; Goa, KL | 1 |
| Higa, S; Islam, MR; Mimura, G; Murakami, K; Wakugami, T | 1 |
| Acchiardo, S; el-Gebely, S; Elmer, DS; Gaber, AO; Gaber, LW; Hathaway, DK | 1 |
| Baroni, MG; Boccuni, ML; Buzzetti, R; Cavallo, MG; Fioriti, E; Mesturino, C; Pozzilli, P; Signore, A; Valente, L; Visalli, N | 1 |
| Ar'Rajab, A; Dawidson, I; Lu, C; Melone, D | 1 |
| Benedetti, E; Gruessner, AC; Gruessner, RW; Papalois, BE; Sutherland, DE; Troppmann, C | 1 |
| Ansara, MF; Brennan, DC; Cryer, PE; Flavin, KS; Lacy, PE; Scharp, DW; White, NH; Zukosky, JM | 1 |
| Bilous, RW; Fioretto, P; Goetz, FC; Mauer, SM; Steffes, MW; Sutherland, DE | 1 |
| Ferguson, CJ; Griffin, PJ; Moore, RH; Salaman, JR | 1 |
| Williams, G | 1 |
| Carotenuto, P; Leslie, RD; Pozzilli, P | 1 |
| Brandstätter, E; Föger, B; König, P; Königsrainer, A; Lechleitner, M; Margreiter, R; Miesenböck, G; Palos, G; Patsch, JR; Ritsch, A | 1 |
| Barker, CF; Brayman, KL; Egidi, MF; Friedman, AL; Grossman, R; Holland, MT; Naji, A; Perloff, J; Samini, F; Tomaszewski, JE | 1 |
| Bretzel, RG; Federlin, K; Geier, C; Groth, CG; Hering, BJ | 1 |
| Ar'Rajab, A; Dawidson, I; Lu, C; Melone, D; Provost, D; Wheeler, D | 1 |
| Abendroth, D; Gräb, C; Mickley, V; Steinbach, G; Storck, M | 1 |
| Bouillon, R; Laureys, J; Mathieu, C; Rutgeerts, O; Waer, M | 1 |
| Bouillon, R; Laureys, J; Mathieu, C; Waer, M | 1 |
| Brennan, DC; Lowell, JA; Miller, SA; Stratta, RJ; Taylor, RJ | 1 |
| Huttunen, KR; Knuuttila, ML; Pernu, HE; Tiilikainen, AS | 1 |
| Gouin, E; Martignat, L; Saï, P; Senecat, O | 1 |
| Gores, PF; Kelley, SL; Lloveras, JJ; Najarian, JS; Stephanian, E; Sutherland, DE | 1 |
| Dupre, J; Mahon, JL; Stiller, CR | 1 |
| Assan, R; Bach, JF; Boitard, C; Bougnères, P; Czernichow, P; Feutren, G; Hannedouche, T; Mihatsch, MJ; Noel, LH; Timsit, J | 1 |
| Robertson, RP; Seaquist, ER; Teuscher, AU | 1 |
| Basta, G; Brunetti, P; Calafiore, R; Calcinaro, F; Falorni, A; Picchio, ML; Pietropaolo, M | 1 |
| Donovan, JP; Langnas, AN; Larsen, JL; Shaw, BW; Sorrell, MF; Stratta, RJ; Taylor, RJ; Trail, KC; Zetterman, RK | 1 |
| Ferguson, R; Henry, M; Osei, K | 1 |
| Cantarovich, D; Dantal, J; Giral, M; Hourmant, M; Karam, G; Paineau, J; Soulillou, JP | 1 |
| Gores, PF; Gruessner, RW; Jones, JW; Matas, AJ | 1 |
| Classen, JB; Shevach, EM | 1 |
| Bach, JF; Beylot, M; Boitard, C; Burcelin, RG; Eddouks, M; Feutren, G; Girard, JR; Landais, P; Normand, S; Riou, JP | 1 |
| Ebeling, P; Knip, M; Koivisto, VA; Leirisalo-Repo, M; Mandrup-Poulsen, T; Pelkonen, R; Tuominen, JA; Turunen, U | 1 |
| Keymeulen, B; Somers, G | 1 |
| Dupre, J; Finegood, DT; Hramiak, IM | 1 |
| Fioretto, P; Gruessner, A; Kunjummen, D; Lokeh, A; Mauer, SM; Moudry-Munns, KC; Schmidt, WJ; Steffes, MW; Stevens, RB; Wang, YL | 1 |
| Baatard, R; Cantarovich, D; Dantal, J; Hourmant, M; Jacques, Y; Le Mauff, B; Murat, A; Paineau, J; Soulillou, JP | 1 |
| Baatard, R; Cantarovich, D; Dantal, J; Hourmant, M; Karam, G; Murat, A; Paineau, J; Soulillou, JP | 1 |
| Mandrup-Poulsen, T; Nerup, J; Nielsen, OJ | 1 |
| Boitard, C; Bougnères, PF; Carel, JC; De Filippo, G | 1 |
| Cushing, KA; Henley, SE; Larsen, JL; Mack-Shipman, L; Miller, SA; Stratta, RJ | 1 |
| Bryer-Ash, M; Byer-Ashe M [corrected to Bryer-Ash, M]; Jaspan, J; Tesi, RJ | 1 |
| Abendroth, D; Mickley, V; Steinbach, G; Storck, M | 1 |
| Alejandro, R; Burke, GW; Ciancio, G; Nery, J; Ricordi, C; Roth, D; Scantlebury, V; Shapiro, R; Skyler, JS; Tzakis, A | 1 |
| Beck-Nielsen, H; Birkeland, SA; Christensen, J; Dieperink, H; Jørgensen, KA; Knudsen, DU; Larsen, KE; Rohr, N; Sjølie, AK; Socci, C | 1 |
| Andreani, D | 1 |
| Chryssochoos, JT; Hagler, MK; Jensen, P; Kapp, JA; Larsen, CP; Linsley, PS; Pearson, TC; Weber, CJ | 1 |
| Barone, GW; Ketel, BL; Reed, K; Turton-Weeks, S | 1 |
| Aasheim, T; Gilmore, T; Leone, J; Papalois, B; Sutherland, DE; Wahoff, D | 1 |
| Cho, YW; Terasaki, PI | 1 |
| Boitard, C; Grünfeld, JP; Hannedouche, TP; Lacour, B; Natov, S | 1 |
| Bone, JM; Bowden, AN; Moore, AP; Rustom, R; Sells, RA | 1 |
| Barcellini, W; Di Marco, R; Grasso, S; Lunetta, M; Magro, G; Meroni, PL; Nicoletti, F; Nicolosi, VM; Zaccone, P | 1 |
| Haberstroh, J; Schorlemmer, HU; Schulte-Mönting, J; von Specht, BU; Wilhelm, T | 1 |
| Assan, R; Boitard, C; Deschamps, I; Jos, J; Laborde, K; Rakotoambinina, B; Robert, JJ; Timsit, J | 1 |
| Drash, AL | 1 |
| Schernthaner, G | 1 |
| Banowsky, LH; Floyd, M; Kothmann, R; Vick, S; Wright, FH | 1 |
| d'Ambrosio, C; De Ciocchis, A; Letizia, C; Pozzilli, P; Scavo, D | 1 |
| Neidhart, M | 1 |
| Bartlett, ST; Drachenberg, CB; Hoehn-Saric, EW; Imbembo, AL; Johnson, LB; Klassen, DK; Kuo, PC; Papadimitriou, JC; Schweitzer, EJ; Weir, MR | 1 |
| Rivereau, AS; Saï, P | 1 |
| Allewaert, K; Bouillon, R; Casteels, K; Laureys, J; Mathieu, C; Waer, M | 1 |
| Baçzkowska, T; Durlik, M; Gaciong, Z; Lao, M; Serafinowicz, A | 1 |
| Bartlett, ST; Delatorre, A; Hadley, GA; Johnson, LB; Kuo, PC; Schweitzer, EJ | 1 |
| Bertuzzi, F; De Nittis, P; Di Carlo, V; Falqui, L; Maffi, P; Piemonti, L; Pozza, G; Scopsi, L; Secchi, A; Socci, C; Taglietti, MV | 1 |
| Bach, JF; Boitard, C; Bougnères, PF; Carel, JC; Eisenbarth, G | 1 |
| Smith, K | 1 |
| Chong, AS; Foster, P; Guo, Z; Jensik, S; McChesney, L; Mital, D; Sankary, H; Shen, J; Tian, Y; Williams, JW; Yin, D | 1 |
| Hahn, HJ; Kuttler, B; Rösing, K | 1 |
| Chong, AS; Foster, PF; Fu, Z; Guo, Z; Jensik, S; McChesney, LP; Mital, D; Sankary, HN; Shen, J; Tian, Y; Williams, JW | 1 |
| Aubrey, MT; Conti, DJ; Freed, BM; Kasten-Jolly, J; Rosano, TG; Ross, JS | 1 |
| Gruessner, RW | 2 |
| Demmy, A; First, MR; Hariharan, S; Munda, R; Rahusen, F | 1 |
| Hricik, DE; Knauss, TC; Phinney, MS; Schulak, JA; Weigel, KA | 1 |
| Dunn, DL; Gruessner, AC; Gruessner, RW; Najarian, JS; Sutherland, DE | 1 |
| Bouillon, R; Casteels, KM; Laureys, JM; Mathieu, C; Overbergh, L; Valckx, D; Waer, M | 1 |
| Kashiwagi, A; Suzuki, E | 1 |
| Kubota, K; Makuuchi, M | 1 |
| Blankenau, R; Keene, JJ; Mattson, JS | 1 |
| Ciurlino, D; Di Carlo, V; Gobbi, C; La Rocca, E; Pozza, G; Secchi, A | 1 |
| Akra, I; Asai, P; Aswad, S; Bogaard, T; Khetan, U; Mendez, R; Mendez, RG; Satterthwaite, R; Shidban, H; Sunga, V | 1 |
| Barrou, BM; Gruessner, AC; Gruessner, RW; Sutherland, DE | 1 |
| Alejandro, R; Burke, GW; Ciancio, G; Miller, J; Ricordi, C; Roth, D; Skyler, JS; Tzakis, A | 1 |
| Büsing, M; Heimes, M; Klempnauer, J; Kozuschek, W; Martin, D; Schulz, T | 1 |
| Bouillon, R; Casteels, K; Laureys, J; Mathieu, C; Valckx, D; Waer, M | 1 |
| Castellón, C; Colina, F; García, I; Gómez, R; Gonzalez-Pinto, I; Loinaz, C; Lumbreras, C; Moreno, E; Perez-Cerdá, F | 1 |
| Conti, DJ; Freed, BM; Isenberg, A; Shen, GK; Singh, TP | 1 |
| Anand, R; Bailey, C; Copley, JB; Hansen, A; Lindberg, J; Staffeld, C; Van Veldhuisen, P | 1 |
| Neylan, JF | 1 |
| Cai, TH; Cigarroa, F; Esterl, RM; Halff, GA; Nichols, L; Speeg, KV | 1 |
| Asolati, M; Benedetti, E; Dunn, T; Holman, D; Lutrin, F; Massad, M; Pollak, R; Raofi, V | 1 |
| Actis, GC; Ciancio, A; Lagget, M; Leone, N; Marzano, A; Rizzetto, M; Salizzoni, M | 1 |
| Dunn, S; Falkenstein, K | 1 |
| Bellissima, G; Burchielli, S; Calabrese, M; Carmellini, M; Del Guerra, S; Giannarelli, R; Marchetti, P; Meacci, L; Mosca, F; Navalesi, R; Solari, R | 1 |
| Anidjar, M; Bedrossian, J; Cattan, P; Desgrandchamps, F; Fornairon, S; Le Duc, A; Legendre, C; Meria, P; Teillac, P | 1 |
| Blancho, G; Cantarovich, D; Dantal, J; Giral-Classe, M; Hourmant, M; Karam, G; Le Normand, L; Soulillou, JP | 1 |
| Haug, MT; Park, MH; Pelegrin, D; Young, JB | 1 |
| Fisher, RK; Flechner, SM; Haug, M; Modlin, CS | 1 |
| Chatzipetrou, M; Kenyon, NS; Masetti, M; Ranuncoli, A; Ricordi, C | 1 |
| Mandrup-Poulsen, T; Nerup, J; Nielsen, FS; Osterby, R; Parving, HH; Rossing, P; Tarnow, L | 1 |
| Akhter, J; Erickson, JM; Frisbie, K; Henley, SA; Larsen, JL; Leone, JP; Lyden, E; Mack-Shipman, LR; Miller, SJ; Ratanasuwan, T; Stratta, RJ; Taylor, R | 1 |
| Angelico, M; Anselmo, A; Baiocchi, L; Casciani, CU; Negrini, S; Orlando, G; Palmieri, G; Pisani, F; Tisone, G; Vennarecci, G | 1 |
| Steen, DC | 1 |
| Deol, HS; Tuch, BE; Wright, DC | 1 |
| Barrou, B; Benalia, H; Bitker, MO; Chatelain, C; Grimaldi, A; Mouquet, C; Ourahma, S; Richard, F | 1 |
| Bilbao, G; Cartner, S; Contreras, JL; Eckhoff, DE; Neville, DM; Ricordi, C; Thomas, FT; Thomas, JM | 1 |
| Gmyr, V; Kerr-Conte, J; Lecomte-Houcke, M; Lefebvre, J; Martinache, I; N'Guyen, H; Noel, C; Pattou, F; Proye, C; Vandewalle, B; Vantyghem, MC | 1 |
| Emre, S; Fishbein, TM; Genyk, Y; Guy, SR; Miller, CM; Schluger, LK; Schwartz, ME; Sheiner, PA | 1 |
| Bonifacio, E; Füchtenbusch, M; Kredel, K; Schnell, O; Ziegler, AG | 1 |
| Alderson, DJ; Lancaster, J; McCormick, M | 1 |
| Chinnakotla, S; Fidler, ME; Hammeke, MD; Leone, JP; Tarantolo, S | 1 |
| Kubota, T; Lynch, SV; Matsunami, H; Morioka, D; Nakatani, Y; Sekido, H; Shimada, H; Strong, RW; Takeda, K; Togo, S | 1 |
| Han, DJ; Jang, HJ; Kim, SC | 1 |
| Lane, JT; Larsen, JL; Leone, JP; Lyden, ER; Mack-Shipman, R; Miller, SA; Ratanasuwan, T; Taylor, RJ | 1 |
| Emre, S; Glabman, S; Guy, S; Miller, C; Mor, E; Patel, T; Schwartz, M; Sheiner, P | 1 |
| Bond, EF; Davis, C; Easterling, T; Munoz-Flores-Thiagarajan, KD | 1 |
| Bouillon, R; Gysemans, C; Laureys, J; Mathieu, C; Waer, M | 2 |
| Bouillon, R; Gysemans, C; Mathieu, C; van Etten, E; Verstuyf, A | 1 |
| Palmer, JP | 1 |
| Bianchi, E; Cristallo, M; Di Carlo, V; Dodesini, R; Luzi, L; Pastore, MR; Piceni Sereni, L; Pozza, G; Secchi, A; Spessot, M; Terruzzi, I | 1 |
| Bonow, RO; Elliott, MD; Gheorghiade, M; Kapoor, A; Kaufman, DB; Parker, MA | 1 |
| Brinkmann, V; Chen, S; Feng, L; Pinschewer, DD | 1 |
| Bayle, F | 1 |
| Han, SB; Jeon, YJ; Kim, HM; Kim, YK; Park, SH; Yang, KH | 1 |
| Abul-Ezz, SR; Barone, GW; Ketel, BL; Lightfoot, ML | 1 |
| Bouillon, R; Gysemans, C; Mathieu, C; Overbergh, L; Van Etten, E; Verstuyf, A; Waer, M | 1 |
| Carstensen, B; Christie, MR; Hawkes, CJ; Mandrup-Poulsen, T; Mølvig, J | 1 |
| Balázsi, I; Bándi, E; Horváth, M; Romics, L; Varsányi, M | 1 |
| Bach, JF; de The, G; Feutren, G | 1 |
| Atkison, P; Bradish, G; Jenner, M; Stiller, C | 1 |
| Arap, S; Fonseca, JA; Ianhez, LE; Sabbaga, E | 1 |
| Koivisto, VA; Leirisalo-Repo, M; Pelkonen, R; Rapola, J; Turunen, U; Viinikka, L; Ylikorkala, O | 1 |
| Feutren, G; Mihatsch, MJ | 1 |
| Fathman, CG; Myers, BD | 1 |
| Cantarovich, D; Hourmant, M; Krempf, M; Lucas, B; Murat, A; Paineau, J; Soulillou, JP | 1 |
| Baatard, R; Cantarovich, D; Dantal, J; Hourmant, M; Murat, A; Paineau, J; Soulillou, JP | 1 |
| Becker, HD; Büsing, M; Hopt, UT; Irkin, I; Pfeffer, F; Schareck, W | 1 |
| Alejandro, R; Carroll, PB; Reyes, J; Ricordi, C; Rilo, H; Shapiro, R; Starzl, TE; Tzakis, A; Zeng, Y | 1 |
| Greulich, B; Mahon, J; Mandrup-Poulsen, T; Martin, S; Pawlowski, B; Ziegler, AG | 1 |
| Heering, P; Rossa, V; Schmitt-Gräff, A; Sundmacher, R | 1 |
| Standl, E; Ziegler, AG | 1 |
| Bertuzzi, F; Braghi, S; Davalli, AM; Falqui, L; Freschi, M; Gavazzi, F; Maffi, P; Ricordi, C; Secchi, A; Socci, C | 1 |
| Farnarier, C; Hermitte, L; Hirn, M; Kaplanski, S; Mattei-Zevacco, C; Schmitt, N; Simonin, G; Vague, P; Vialettes, B | 1 |
| Greiner, DL; Handler, ES; Mordes, JP; Rossini, AA | 1 |
| Daley, TD; Mamandras, AH; Wysocki, GP | 1 |
| Assan, R; Bach, JF; Chatenoud, L; Debray-Sachs, M; Feutren, G; Laborie, C; Quiniou-Debrie, MC; Thomas, G | 1 |
| Gunn, HC; Hanglow, AC; Hiestand, PC | 1 |
21 review(s) available for cyclosporine and Autoimmune Diabetes
| Article | Year |
|---|---|
Mycobacterium genavense-induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature.
Topics: Abdomen; Adolescent; Alemtuzumab; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Antibodies, Monoclonal, Humanized; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Cyclosporine; Diabetes Mellitus, Type 1; Diarrhea; Genetic Diseases, X-Linked; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytes; Humans; Immune System Diseases; Immunosuppressive Agents; Lymph Nodes; Male; Melphalan; Mycobacterium Infections, Nontuberculous; Mycophenolic Acid; Nontuberculous Mycobacteria; Photopheresis; Polymerase Chain Reaction; Transplantation Conditioning; Vidarabine | 2017 |
A historical view from thirty eventful years of immunotherapy in autoimmune diabetes.
Topics: Animals; Antibodies, Monoclonal; Autoantigens; CD3 Complex; Cyclosporine; Diabetes Mellitus, Type 1; History, 20th Century; Humans; Immunotherapy; Insulin-Secreting Cells; Self Tolerance | 2011 |
Immunotherapies in diabetes mellitus type 1.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Azathioprine; Basiliximab; Chaperonin 60; Cyclosporine; Daclizumab; Diabetes Mellitus, Type 1; Diet; Etanercept; Exenatide; Fatty Acids, Unsaturated; Glutamate Decarboxylase; Humans; Hypoglycemic Agents; Immunoconjugates; Immunoglobulin G; Immunosuppressive Agents; Insulin; Interferon-alpha; Interleukin 1 Receptor Antagonist Protein; Islets of Langerhans Transplantation; Niacinamide; Peptide Fragments; Peptides; Primary Prevention; Pyrazines; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rituximab; Secondary Prevention; Sitagliptin Phosphate; Tertiary Prevention; Triazoles; Venoms; Vitamin D; Vitamins | 2012 |
Primary and secondary prevention of Type 1 diabetes.
Topics: Abatacept; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Autoantibodies; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Diet; Fatty Acids, Omega-3; Female; Glutamate Decarboxylase; Glutens; Humans; Hypoglycemic Agents; Immunoconjugates; Infant; Infant Formula; Infant, Newborn; Insulin; Male; Niacinamide; Primary Prevention; Secondary Prevention; Vitamin D | 2013 |
Sirolimus and islet transplants.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Type 1; Drug Synergism; Humans; Immunosuppressive Agents; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Rats; Sirolimus; Swine; Transplantation, Heterologous | 2003 |
New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Humans; Immunosuppressive Agents; Organ Transplantation; Prospective Studies; Retrospective Studies; Tacrolimus; Time Factors | 2004 |
ISAtx-247 (Isotechnika/Roche).
Topics: Animals; Arthritis, Experimental; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Psoriasis; Structure-Activity Relationship | 2004 |
FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.
Topics: Adult; Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Cholangitis; Cyclosporine; Diabetes Mellitus, Type 1; Digestive System Diseases; Disease Models, Animal; Drug Evaluation; Drug Evaluation, Preclinical; Female; Humans; Kidney Diseases; Male; Mice; Multiple Sclerosis; Nephrotic Syndrome; Psoriasis; Rats; Swine; Tacrolimus | 1993 |
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Digestive System Diseases; Eye Diseases; Humans; Immune System Diseases; Nephrotic Syndrome; Nervous System Diseases; Skin Diseases | 1993 |
New developments in non-specific and semi-specific immunosuppression in type I diabetes.
Topics: Animals; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Insulin; Lymphokines; Photopheresis; Prediabetic State | 1993 |
Lessons learned from use of cyclosporine for insulin-dependent diabetes mellitus. The case for immunotherapy for insulin-dependent diabetics having residual insulin secretion.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Humans; Immunotherapy; Insulin; Insulin Secretion; Islets of Langerhans; Randomized Controlled Trials as Topic | 1993 |
Immunointervention in type 1 (insulin-dependent) diabetes mellitus.
Topics: Animals; Autoimmune Diseases; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Immunosuppressive Agents; Mice; Mice, Inbred NOD; Prediabetic State; Rats; Rats, Inbred BB | 1993 |
Progress in the immunointervention of type-1 diabetes mellitus.
Topics: BCG Vaccine; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Immunotherapy; Insulin; Niacinamide | 1995 |
[Remission of diabetes mellitus].
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Injections, Subcutaneous; Insulin; Insulin Infusion Systems; Insulin Resistance; Randomized Controlled Trials as Topic; Remission Induction | 1997 |
[Pancreas transplantation for patients with IDDM].
Topics: Animals; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Graft Survival; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Islets of Langerhans Transplantation; Organ Preservation; Pancreas Transplantation; Swine | 1997 |
Antibody induction therapy in pancreas transplantation.
Topics: Animals; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Muromonab-CD3; Pancreas Transplantation; T-Lymphocytes; Tacrolimus | 1998 |
Islet transplantation: present and future perspectives.
Topics: Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Islets of Langerhans Transplantation; Tacrolimus; Tissue Donors | 1998 |
The current state of pancreas transplantation.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Pancreas Transplantation; Treatment Outcome | 1999 |
FTY720: altered lymphocyte traffic results in allograft protection.
Topics: Animals; Autoimmune Diseases; Cell Movement; Chemokines; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Humans; Immunologic Memory; Immunosuppressive Agents; Inflammation; Islets of Langerhans Transplantation; Lymphocyte Activation; Lymphocytes; Models, Animal; Propylene Glycols; Safety; Sphingosine; Transplantation, Homologous | 2001 |
[Cyclosporin A in therapy of type I diabetes?].
Topics: Autoimmune Diseases; Cyclosporine; Diabetes Mellitus, Type 1; Humans | 1991 |
Insulin dependent diabetes mellitus hypothesis of autoimmunity.
Topics: Animals; Antibody Formation; Autoimmune Diseases; Azathioprine; Cyclosporine; Cytotoxicity, Immunologic; Diabetes Mellitus, Type 1; Environment; Humans; Islets of Langerhans; Mice; Mice, Inbred NOD; Prednisone; Rats; Rats, Inbred BB; Thymus Gland | 1991 |
47 trial(s) available for cyclosporine and Autoimmune Diabetes
| Article | Year |
|---|---|
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation.
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Prospective Studies; Sirolimus; Steroids; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2013 |
Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus.
Topics: Adolescent; Blood Glucose; Child; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Male; Methotrexate; Pilot Projects; Remission Induction | 2010 |
[TAC/MMF/Pred/single shot ATG versus CsA/MMF/Pred single shot ATG after pancreas-/kidney transplantation (PNTX)--initial results of a prospective randomized study].
Topics: Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Prednisone; Prospective Studies; Tacrolimus; Treatment Outcome | 1998 |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
Topics: Acute Disease; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Emulsions; Europe; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Israel; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Safety; Tacrolimus | 2004 |
Rejection after simultaneous pancreas-kidney transplantation.
Topics: Adolescent; Adult; Biopsy; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease-Free Survival; Drug Therapy, Combination; Emulsions; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Postoperative Complications; Tacrolimus | 2005 |
Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
Topics: Adolescent; Adult; Biopsy; Cyclosporine; Diabetes Mellitus, Type 1; Emulsions; Europe; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Israel; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Prospective Studies; Safety; Tacrolimus; Treatment Outcome | 2005 |
Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
Topics: Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Leukocyte Count; Mycophenolic Acid; Pancreas Transplantation; Tacrolimus; Time Factors; Treatment Outcome | 2005 |
A large, prospective, randomized, open-label, multicentre study of corticosteroid withdrawal in SPK transplantation: a 3-year report.
Topics: Biopsy; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Europe; Feasibility Studies; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Israel; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Prospective Studies; Safety; Tacrolimus; Time Factors; Treatment Outcome; Withholding Treatment | 2005 |
Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
Topics: Adult; Age Factors; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Europe; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Israel; Kidney Failure, Chronic; Kidney Transplantation; Laparotomy; Middle Aged; Pancreas Transplantation; Postoperative Complications; Prospective Studies; Reoperation; Survival Rate; Tacrolimus; Treatment Outcome | 2005 |
Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Prednisone; Prospective Studies; Survival Rate; Transplantation Immunology; Treatment Outcome | 2005 |
Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation.
Topics: Adult; Amylases; Biomarkers; Blood Glucose; Cadaver; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Recurrence; Tacrolimus; Time Factors; Tissue Donors; Urine | 1995 |
Corticosteroid withdrawal after liver transplantation.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Humans; Hypercholesterolemia; Hypertension; Immunosuppressive Agents; Liver Diseases; Liver Function Tests; Liver Transplantation | 1995 |
Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Age of Onset; Child; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Follow-Up Studies; Humans; Insulin; Niacinamide | 1995 |
Cyclosporine blood levels predict the likelihood of rejection and toxicity after simultaneous pancreas-kidney transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Monitoring; Female; Graft Rejection; Graft Survival; Humans; Incidence; Kidney Transplantation; Male; Pancreas Transplantation; Probability; Survival Rate | 1995 |
Modification of methodology results in improvement in simultaneous kidney-islet success.
Topics: Antilymphocyte Serum; Azathioprine; C-Peptide; Cells, Cultured; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Immunosuppression Therapy; Islets of Langerhans; Islets of Langerhans Transplantation; Kidney Failure, Chronic; Kidney Transplantation; Muromonab-CD3; Postoperative Complications; Prednisone; Tissue Preservation; Transplantation, Heterotopic; Transplantation, Homologous | 1995 |
Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol.
Topics: Adult; Azathioprine; Cholesterol, HDL; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoprotein Lipase; Male; Pancreas Transplantation; Prednisone; Triglycerides | 1994 |
Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Administration Schedule; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Pancreas Transplantation; Predictive Value of Tests; Prednisone | 1994 |
Cyclosporine levels in diabetic (type 1) patients undergoing kidney and pancreas transplantation: role of a new galenica formulation.
Topics: Administration, Oral; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Kidney Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Pancreas Transplantation; Radioimmunoassay | 1994 |
Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Guanidines; Humans; Immunosuppressive Agents; Insulin; Islets of Langerhans Transplantation; Kidney Transplantation; Male; Prednisone; Tissue Donors | 1993 |
Determinants of clinical remission in recent-onset IDDM.
Topics: Adult; Biomarkers; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Glucose Tolerance Test; Humans; Immunotherapy; Insulin; Insulin Secretion; Methylprednisolone | 1993 |
Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin.
Topics: Actuarial Analysis; Adult; Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Histocompatibility Testing; Humans; Immunosuppression Therapy; Interleukin-2; Kidney Transplantation; Male; Methylprednisolone; Pancreas Transplantation; Rabbits; Survival Analysis; Time Factors | 1993 |
Deficiency of erythropoietin is not responsible for the anaemia associated with cyclosporin treatment of insulin-dependent diabetes mellitus. Canadian-European Randomized Control Trial Group.
Topics: Adolescent; Adult; Anemia; Autoimmune Diseases; Child; Cyclosporine; Diabetes Mellitus, Type 1; Double-Blind Method; Erythropoietin; Follow-Up Studies; Humans; Prospective Studies; Time Factors | 1993 |
Long-term results of early cyclosporin therapy in juvenile IDDM.
Topics: Autoantibodies; C-Peptide; Child; Cyclosporine; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Insulin; Islets of Langerhans; Longitudinal Studies; Prognosis | 1996 |
Lipids following pancreas transplantation in recipients receiving FK 506.
Topics: Adult; Arteriosclerosis; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Lipids; Male; Pancreas Transplantation; Risk Factors; Tacrolimus | 1995 |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression.
Topics: Blood Glucose; C-Peptide; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycated Hemoglobin; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Pancreas Transplantation; Tacrolimus | 1995 |
Angiotensin converting enzyme inhibition and chronic cyclosporine-induced renal dysfunction in type 1 diabetes.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Radioimmunoassay; Renal Circulation; Sodium | 1996 |
Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
Topics: Adolescent; Adult; Arginine; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Reference Values | 1995 |
Serum angiotensin-converting enzyme levels in patients with recent-onset insulin-dependent diabetes after one year of low-dose cyclosporin therapy. IMDIAB Study Group.
Topics: Adolescent; Adult; Blood Pressure; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Peptidyl-Dipeptidase A | 1995 |
Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy.
Topics: Adult; Biopsy, Needle; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas; Pancreas Transplantation; Prospective Studies; Tacrolimus; Ultrasonography, Interventional | 1996 |
Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children.
Topics: Adolescent; Autoantibodies; Blood Glucose; Child; Cohort Studies; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Drug Tolerance; Female; Glucose Intolerance; Humans; Immunosuppressive Agents; Insulin; Insulin Antibodies; Insulin Secretion; Islets of Langerhans; Male; Prediabetic State; Prospective Studies; Time Factors | 1996 |
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Case-Control Studies; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Gastrointestinal Diseases; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Kidney Transplantation; Lymphoma; Male; Muromonab-CD3; Mycophenolic Acid; Nervous System Diseases; Pancreas Transplantation; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate; Tacrolimus; Transplantation, Homologous | 1997 |
Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Prednisone; Tacrolimus; Uremia | 1997 |
Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: results of a prospective randomized single-center study.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Pancreas Transplantation; Prospective Studies; Tacrolimus; Transplantation, Homologous | 1998 |
Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Blood Pressure; Bone Density; Cholesterol; Cyclosporine; Diabetes Mellitus, Type 1; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Hepatitis; Humans; Immunosuppressive Agents; Liver Transplantation; Prospective Studies; Steroids; Time Factors | 1998 |
Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.
Topics: Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Diabetes Mellitus, Type 1; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Lipids; Prevalence; Tacrolimus | 1998 |
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group.
Topics: Bias; Black People; Cadaver; Cross-Over Studies; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; Humans; Hypoglycemic Agents; Immunosuppression Therapy; Immunosuppressive Agents; Insulin; Kidney Transplantation; Postoperative Complications; Survival Rate; Tacrolimus; Time Factors; Tissue Donors; United States; White People | 1998 |
Long-term outcome of kidney transplantation after steroid withdrawal.
Topics: Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Drug Administration Schedule; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Retrospective Studies; Steroids; Survival Rate; Time Factors | 1998 |
Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation.
Topics: Adrenal Cortex Hormones; Adult; Animals; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Prospective Studies; Rabbits; Safety | 1998 |
Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.
Topics: Adult; Albuminuria; Blood Pressure; Cyclosporine; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney; Longitudinal Studies; Male | 1999 |
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation.
Topics: Adult; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pilot Projects; Prednisone; Prospective Studies; RNA, Messenger; RNA, Viral; Time Factors | 1999 |
Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.
Topics: Adolescent; Adult; Antibodies; Antibody Formation; Autoantibodies; Autoantigens; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Humans; Hypoglycemic Agents; Immunoglobulin G; Insulin; Islets of Langerhans; Th2 Cells | 2000 |
Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506.
Topics: Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney; Liver Transplantation; Male; Postoperative Complications; Tacrolimus; Time Factors | 1994 |
IA-2 antibody-negative status predicts remission and recovery of C-peptide levels in type 1 diabetic patients treated with cyclosporin.
Topics: Adult; Autoantibodies; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Male; Placebos; Predictive Value of Tests; Time Factors | 2002 |
Epstein-Barr virus serology and isoelectrofocusing pattern of serum immunoglobulins in cyclosporin or placebo-treated type I diabetics.
Topics: Adolescent; Adult; Antibodies, Viral; Antigens, Viral; Autoimmune Diseases; Blood Protein Electrophoresis; Capsid Proteins; Cyclosporine; Diabetes Mellitus, Type 1; Epstein-Barr Virus Nuclear Antigens; Herpesvirus 4, Human; Humans; Immunoglobulin G; Immunoglobulins; Immunosuppression Therapy; Isoelectric Focusing; Lymphoma, B-Cell; Lymphoproliferative Disorders; Random Allocation; Single-Blind Method; Tumor Virus Infections | 1992 |
Renal transplantation in diabetic patients: a survey of 100 cases.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Graft Survival; Humans; Kidney Transplantation; Male; Prednisone; Retrospective Studies; Survival Analysis; Time Factors | 1992 |
Lipid metabolism following heterotopic pancreas transplantation with special reference to steroid therapy.
Topics: Adult; Azathioprine; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppression Therapy; Male; Pancreas Transplantation; Prednisolone; Transplantation, Heterotopic; Triglycerides | 1992 |
Natural course of remission in IDDM during 1st yr after diagnosis.
Topics: Adult; Autoantibodies; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Antibodies; Islets of Langerhans; Male; Probability; Remission, Spontaneous | 1992 |
141 other study(ies) available for cyclosporine and Autoimmune Diabetes
| Article | Year |
|---|---|
Lack of Improvement in Insulin Sensitivity After Pancreas Transplantation in Recipients With a High Level of Calcineurin Inhibitors.
Topics: Adult; Blood Glucose; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Kaplan-Meier Estimate; Male; Middle Aged; Pancreas Transplantation; Tacrolimus | 2021 |
Development of hemolytic paroxysmal nocturnal hemoglobinuria without graft loss following hematopoietic stem cell transplantation for acquired aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Cells; Chimerism; Cyclosporine; Diabetes Mellitus, Type 1; Graft Survival; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Immunosuppressive Agents; Male; Membrane Proteins; Mutation; Neutrophils; Recurrence; Thrombocytopenia; Thrombosis; Treatment Outcome | 2019 |
Tolerogenic vaccine composited with islet-derived multipeptides and cyclosporin A induces pTreg and prevents Type 1 diabetes in murine model.
Topics: Animals; Cyclosporine; Dendritic Cells; Diabetes Mellitus, Type 1; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; T-Lymphocytes, Regulatory; Vaccines | 2020 |
Proposal for generating new beta cells in a muted immune environment for type 1 diabetes.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Gastrins; Humans; Immune Tolerance; Insulin-Secreting Cells; Lansoprazole; Mice; Pancreatic Ducts; Prospective Studies; Proton Pump Inhibitors; Regeneration; Species Specificity | 2013 |
Assessing the effect of immunosuppression on engraftment of pancreatic islets.
Topics: Animals; Azathioprine; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Immunosuppression Therapy; Immunosuppressive Agents; Islets of Langerhans Transplantation; Models, Animal; Prednisone; Swine; Swine, Miniature; Transplantation Tolerance; Transplantation, Homologous | 2013 |
Juvenile ulcerated necrobiosis lipoidica successfully treated with oral cyclosporin A.
Topics: Abdomen; Administration, Oral; Adolescent; Breast; Cyclosporine; Dermatologic Agents; Diabetes Mellitus, Type 1; Female; Humans; Leg; Necrobiosis Lipoidica; Risk Factors; Treatment Outcome | 2013 |
Diagnostic and management dilemma of a pancreas-kidney transplant recipient with aplastic anaemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Prednisolone; Tacrolimus | 2014 |
Long-term disease course in a patient with severe neonatal IPEX syndrome.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Diarrhea; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Follow-Up Studies; Genetic Diseases, X-Linked; Glomerular Filtration Rate; Glucocorticoids; Humans; Immune System Diseases; Immunoglobulin E; Immunosuppressive Agents; Infant, Newborn; Liver Cirrhosis; Male; Mycophenolic Acid; Prednisolone; Young Adult | 2015 |
Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury.
Topics: Animals; Apoptosis; Biomarkers; Combined Modality Therapy; Coronary Vessels; Cyclosporine; Cytokines; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Heart; Immunosuppressive Agents; In Vitro Techniques; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Random Allocation; Rats, Wistar; Streptozocin | 2017 |
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Cyclosporine; Diabetes Mellitus, Type 1; Dyslipidemias; End Stage Liver Disease; Female; Follow-Up Studies; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Male; Metabolic Syndrome; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prevalence; Prospective Studies; Risk Factors; Severity of Illness Index; Spain; Survival Analysis; Tacrolimus; Transplant Recipients | 2017 |
Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.
Topics: Adult; Cross-Over Studies; Cyclosporine; Diabetes Mellitus, Type 1; Drug Interactions; Female; Humans; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Transplantation | 2008 |
Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Etanercept; Everolimus; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Recurrence; Sirolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice.
Topics: Age Factors; Animals; Autoantibodies; Cyclosporine; Diabetes Mellitus, Type 1; Female; Glutamate Decarboxylase; Insulin; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Pancreas; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Inbred BB | 2009 |
Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome.
Topics: Adult; C-Reactive Protein; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Mycophenolic Acid; Protoporphyria, Erythropoietic; Raynaud Disease | 2009 |
Targeting cyclophilin D and the mitochondrial permeability transition enhances beta-cell survival and prevents diabetes in Pdx1 deficiency.
Topics: Animals; Animals, Newborn; Apoptosis; Cell Line; Cell Survival; Cyclophilins; Cyclosporine; Diabetes Mellitus, Type 1; Homeodomain Proteins; Humans; Insulin-Secreting Cells; Membrane Potential, Mitochondrial; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Necrosis; Peptidyl-Prolyl Isomerase F; Trans-Activators | 2010 |
Circulating cytokines are associated with human islet graft function in type 1 diabetes.
Topics: Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Cytokines; Diabetes Mellitus, Type 1; Female; Graft Rejection; Humans; Immunosuppressive Agents; Islets of Langerhans Transplantation; Kidney Transplantation; Male; Mycophenolic Acid | 2011 |
Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil.
Topics: Cyclosporine; Dermatologic Agents; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Pemphigoid, Bullous; Prednisolone; Treatment Outcome | 2012 |
Immunomodulators: Cell savers.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Humans; Immunity, Innate; Immunotherapy; Insulin-Secreting Cells; Mice; T-Lymphocytes; Vitamin D | 2012 |
Low doses of anti-CD3, ciclosporin A and the vitamin D analogue, TX527, synergise to delay recurrence of autoimmune diabetes in an islet-transplanted NOD mouse model of diabetes.
Topics: Alkynes; Animals; Antibodies, Monoclonal; CD3 Complex; Cell Proliferation; Cholecalciferol; Cyclosporine; Diabetes Mellitus, Type 1; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Female; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred NOD; Secondary Prevention; T-Lymphocytes; Vitamin D | 2012 |
Insulin independence after conversion from tacrolimus to cyclosporine in islet transplantation.
Topics: Area Under Curve; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Hyperglycemia; Hypoglycemia; Immune Tolerance; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Middle Aged; Tacrolimus | 2012 |
Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Prednisolone; Prednisone; Tacrolimus; Time Factors; Treatment Failure; Treatment Outcome | 2002 |
Severe resistant subacute prurigo successfully controlled by long-term cyclosporin.
Topics: Administration, Oral; Back; Cyclosporine; Dermatologic Agents; Diabetes Mellitus, Type 1; Drug Resistance, Multiple; Female; Humans; Middle Aged; Prurigo | 2003 |
A dithiocarbamate analogue decreases intraislet cell infiltration and the incidence of diabetes mellitus in the genetic diabetes-prone BB rat.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hyperglycemia; Immunohistochemistry; Immunosuppressive Agents; Insulin; Islets of Langerhans; Lymphocytes; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Inbred BB; Survival Analysis; Thiocarbamates; Time Factors | 2004 |
Kinetics of diabetes-associated autoantibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes.
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Humans; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans Transplantation; Isoenzymes; Kidney Transplantation; Kinetics; Mycophenolic Acid; Pancreas; Prognosis | 2003 |
The use of cyclosporine in renal and pancreas transplantation.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Pancreas Transplantation; Retrospective Studies; Survival Analysis | 2004 |
Pancreas-kidney transplantation in Japan: impact of cyclosporine on the development of immunosuppressive therapy.
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Graft Survival; Humans; Immunosuppressive Agents; Japan; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus.
Topics: Adult; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Female; Glucose; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Postoperative Period; Tacrolimus; Time Factors | 2004 |
Impact of kidney transplantation on glycemic control and cardiovascular risk factors in insulin-treated diabetic patients receiving cyclosporine: a longitudinal study.
Topics: Adult; Cardiovascular Diseases; Cyclosporine; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Insulin; Kidney Transplantation; Lipids; Longitudinal Studies; Male; Middle Aged; Risk Factors; Time Factors | 2004 |
C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
Topics: Administration, Oral; Area Under Curve; Cyclosporine; Diabetes Mellitus, Type 1; Drug Monitoring; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Intestinal Absorption; Male; Middle Aged; Time Factors | 2005 |
Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Treatment Outcome | 2006 |
Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation.
Topics: Area Under Curve; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Emulsions; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Postoperative Period; Prednisone; Regression Analysis; Reproducibility of Results | 2006 |
Functional and histological evaluation of transplanted pancreatic islets immunoprotected by PEGylation and cyclosporine for 1 year.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Type 1; Glucose Tolerance Test; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Polyethylene Glycols; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Surface Properties; Time Factors; Transplantation, Homologous | 2007 |
Long-term graft function after allogeneic islet transplantation.
Topics: Adult; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Insulin; Islets of Langerhans Transplantation; Kidney Transplantation; Mercaptopurine; Prednisone; Transplantation, Homologous | 2007 |
Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus.
Topics: Adolescent; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Pancreas Transplantation; Renal Dialysis; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus; Treatment Outcome | 2008 |
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; B-Lymphocytes; Combined Modality Therapy; Cyclosporine; Diabetes Mellitus, Type 1; Drug Delivery Systems; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukapheresis; Lupus Erythematosus, Systemic; Rituximab; T-Lymphocytes; Treatment Outcome | 2008 |
Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients.
Topics: Adolescent; Adult; Arterioles; Atrophy; Biopsy; Cyclosporine; Diabetes Mellitus, Type 1; Female; Fibrosis; Humans; Kidney; Kidney Glomerulus; Male; Pancreas Transplantation; Renal Circulation | 1995 |
Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Apolipoproteins A; Apolipoproteins B; Cardiovascular Diseases; Child; Cholesterol; Cyclosporine; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Gemfibrozil; Graft Occlusion, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Isoenzymes; Kidney; Kidney Function Tests; Kidney Transplantation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Ischemia; Peritoneal Dialysis, Continuous Ambulatory; Radioimmunoassay; Reference Values; Renal Dialysis; Triglycerides; Ultrasonography | 1995 |
[Use of cyclosporin A for remission induction in newly-detected insulin-dependent diabetes].
Topics: C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Insulin; Remission Induction | 1994 |
Aberrant distribution of CD4 and CD8 lymphocyte subsets in recent-onset IDDM patients. Effect of cyclosporin.
Topics: Adult; Antibodies, Monoclonal; Antigens, CD; CD4-CD8 Ratio; Cyclosporine; Diabetes Mellitus, Type 1; Fluorescent Antibody Technique; Humans; Integrin beta1; Leukocyte Common Antigens; Prospective Studies; Protein Tyrosine Phosphatase, Non-Receptor Type 1; T-Lymphocyte Subsets | 1993 |
Effect of FK506 on the development of diabetes in BB rats in comparison with that of cyclosporin.
Topics: Aging; Animals; Cyclosporine; Diabetes Mellitus, Type 1; Female; Fluorescent Antibody Technique; Lymphocyte Subsets; Male; Pancreas; Rats; Rats, Inbred BB; Tacrolimus | 1993 |
An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation.
Topics: Adult; Blood Glucose; Cadaver; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Weight Gain | 1995 |
Early endocrine pancreas graft function and outcome after simultaneous pancreas-kidney transplantation.
Topics: Adult; Age Factors; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Humans; Insulin; Kidney Transplantation; Middle Aged; Pancreas Transplantation; Prednisone; Retrospective Studies; Tissue Donors; Treatment Outcome | 1995 |
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys.
Topics: Adolescent; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glomerular Mesangium; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Glomerulus; Male; Middle Aged; Pancreas Transplantation; Time Factors | 1993 |
Effect of pancreas transplantation on glomerular structure in diabetes.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Kidney Glomerulus; Pancreas Transplantation | 1994 |
IDDM: long honeymoon, sweet ending.
Topics: Animals; Chaperonin 60; Cyclosporine; Diabetes Mellitus, Type 1; Female; Heat-Shock Proteins; Humans; Male; Mice; Mice, Inbred NOD; Mycobacterium bovis | 1994 |
Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Administration Schedule; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Pancreas Transplantation; Prednisone; Retrospective Studies; Time Factors | 1994 |
Immunosuppression in pancreatic islet cell transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Guanidines; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Islets of Langerhans Transplantation; Kidney Transplantation; Prednisolone; Retrospective Studies | 1994 |
Activated form of vitamin D [1,25(OH)2D3] and its analogs are dose-reducing agents for cyclosporine in vitro and in vivo.
Topics: Animals; Calcitriol; Cells, Cultured; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Islets of Langerhans Transplantation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred NOD; T-Lymphocytes; Transplantation, Isogeneic | 1994 |
Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine.
Topics: Animals; Calcitriol; Cyclosporine; Diabetes Mellitus, Type 1; Drug Synergism; Graft Survival; Immunosuppressive Agents; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Time Factors; Transplantation, Isogeneic | 1994 |
Cyclosporine challenge in the decision of combined kidney-pancreas versus solitary pancreas transplantation.
Topics: Adult; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Graft Survival; Humans; Kidney Transplantation; Male; Pancreas Transplantation; Proteinuria | 1994 |
Drug-induced gingival overgrowth and class II major histocompatibility antigens.
Topics: Adult; Amlodipine; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Felodipine; Female; Gingiva; Gingival Diseases; Histocompatibility Testing; HLA-DR Antigens; Humans; Kidney Transplantation; Male; Nifedipine; Retrospective Studies; Risk Factors | 1994 |
Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.
Topics: Animals; Animals, Newborn; Autoimmune Diseases; Cyclosporine; Diabetes Mellitus, Type 1; Female; Islets of Langerhans; Lymphocyte Activation; Male; Mice; Mice, Inbred NOD; Spleen; T-Lymphocyte Subsets | 1994 |
The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study.
Topics: Adult; Atrophy; Biopsy; Child; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Fibrosis; Follow-Up Studies; Humans; Kidney; Kidney Tubules; Risk Factors | 1994 |
Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients.
Topics: Adult; Arginine; Arthritis; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Glucose; Humans; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Transplantation; Male; Pancreas Transplantation; Prednisone; Psoriasis; Transplantation, Homologous | 1994 |
Preventive effects of azathioprine (AZA) on the onset of diabetes mellitus in NOD mice.
Topics: Animals; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Islets of Langerhans; Male; Mice; Mice, Inbred NOD; Pancreas | 1993 |
Orthotopic hepatic transplantation in patients with type I diabetes mellitus.
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Liver Transplantation; Male; Pancreas Transplantation; Prednisone; Risk Factors; Survival Rate | 1994 |
Differential effects of systemic insulin delivery and prednisone on tissue glucose and insulin sensitivity in insulin-dependent diabetes mellitus pancreas recipients.
Topics: Adult; Azathioprine; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glucose; Homeostasis; Humans; Immunotherapy; Insulin; Insulin Resistance; Kidney Transplantation; Kinetics; Male; Pancreas Transplantation; Prednisone; Tolbutamide; Transplantation, Heterotopic | 1994 |
OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Pancreas Transplantation; Prednisolone | 1994 |
Hypoaldosteronemic hyporeninemic hyperkalemia after renal transplantation.
Topics: Adult; Aldosterone; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Fludrocortisone; Humans; Hyperkalemia; Immunosuppressive Agents; Islets of Langerhans Transplantation; Kidney Transplantation; Male; Potassium; Renin | 1993 |
Post-thymectomy organ-specific autoimmunity: enhancement by cyclosporine A and inhibition by IL-2.
Topics: Animals; Animals, Newborn; Autoantibodies; Autoimmune Diseases; Autoimmunity; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Female; Gastritis; Interleukin-2; Male; Mice; Mice, Inbred C3H; Mice, Inbred NOD; Self Tolerance; Thymectomy | 1993 |
Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
Topics: Adult; Analysis of Variance; Autoantibodies; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Female; Glucose Clamp Technique; Glycated Hemoglobin; HLA-DQ Antigens; HLA-DR Antigens; Humans; Insulin; Insulin Antibodies; Islets of Langerhans; Male; Reference Values | 1993 |
Seven years of remission in a type I diabetic patient.
Topics: Adolescent; Autoantibodies; Blood Glucose; Body Composition; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Follow-Up Studies; Glucose; Glycated Hemoglobin; Humans; Insulin; Islets of Langerhans; Male; Proinsulin; Remission, Spontaneous | 1993 |
Correlation of preoperative renal function and identification of risk factors for eventual native renal failure in cyclosporine-treated nonuremic diabetic recipient of pancreas transplants alone.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Pancreas Transplantation; Retrospective Studies; Risk Factors | 1993 |
Simultaneous pancreatic and kidney transplantation before end-stage chronic renal failure.
Topics: Adult; Azathioprine; Blood Glucose; C-Peptide; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Pancreas Transplantation | 1993 |
Conversion of pancreas transplants to FK 506 from CsA.
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Safety; Tacrolimus | 1995 |
Cyclosporine resorption in diabetic patients after simultaneous pancreas and kidney transplantation.
Topics: Adult; Biological Availability; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gastroparesis; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Transplantation; Middle Aged; Pancreas Transplantation | 1995 |
Islet and kidney transplantation using ATG and cyclosporin monotherapy and a central facility for islet isolation and purification.
Topics: Adult; Antilymphocyte Serum; Blood Glucose; C-Peptide; Cell Separation; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Kidney Transplantation; Male; Middle Aged; T-Lymphocytes | 1995 |
[Prevention of juvenile diabetes (type 1): reality or fiction?].
Topics: Adolescent; Autoimmunity; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Infant; Infant, Newborn; Insulin; Insulin Antibodies; Insulin Secretion; Niacinamide; Primary Prevention | 1994 |
CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic Nod mice.
Topics: Abatacept; Animals; Antigens, CD; Antigens, Differentiation; Capsules; CTLA-4 Antigen; Cyclosporine; Diabetes Mellitus, Type 1; Graft Survival; Immunoconjugates; Immunosuppressive Agents; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Microspheres; Rabbits; Time Factors; Transplantation, Heterologous | 1996 |
Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Pancreas Transplantation; Retrospective Studies; Tacrolimus; Time Factors | 1996 |
The effect of 15-deoxyspergualin on islet allograft survival in the canine model.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Dogs; Drug Therapy, Combination; Graft Survival; Guanidines; Immunosuppressive Agents; Islets of Langerhans Transplantation; Pancreatectomy; Transplantation, Autologous; Transplantation, Homologous | 1996 |
Comparison of kidney graft survival in Asian and Caucasian patients transplanted in the United States.
Topics: Adolescent; Adult; Age Factors; Asia; Cyclosporine; Cytomegalovirus Infections; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organ Preservation; Regression Analysis; Risk Factors; Sex Factors; Survival Rate; Tissue Donors; United States; White People | 1996 |
Cyclosporin-induced cerebellar syndrome in a pancreatico-renal transplant recipient.
Topics: Adult; Cerebellar Diseases; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Kidney Transplantation; Pancreas Transplantation; Syndrome | 1996 |
Synergistic effect of deoxyspergualin (DSP) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Drug Synergism; Female; Guanidines; Immunosuppressive Agents; Male; Rats; Rats, Inbred BB | 1996 |
Prevention of type I diabetes in the non-obese diabetic (NOD) mouse with 15-deoxyspergualin (15-DS) or 15-DS + cyclosporin A (CyA).
Topics: Animals; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Guanidines; Hypoglycemic Agents; Immunosuppressive Agents; Male; Mice; Mice, Inbred NOD; Random Allocation | 1995 |
Is it time to draw the curtain on immune intervention trials in newly diagnosed patients with IDDM?
Topics: Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Immunosuppressive Agents; Multicenter Studies as Topic; Research Design; Treatment Failure | 1995 |
Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
Topics: Actuarial Analysis; Adolescent; Adult; Age Factors; Antilymphocyte Serum; Cadaver; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisone; Retrospective Studies; Tissue Donors | 1996 |
Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats.
Topics: Animals; Arthritis, Experimental; Autoimmune Diseases; Bromocriptine; Cyclosporine; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Drug Synergism; Female; Male; Ornithine Decarboxylase; Polyarteritis Nodosa; Rats; Rats, Inbred BB; Rats, Inbred Lew; Rats, Sprague-Dawley; Thymus Gland; Uveitis | 1996 |
Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
Topics: Administration, Oral; Adoptive Transfer; Animals; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Escherichia coli; Female; Glycoproteins; Humans; Immunosuppressive Agents; Insulin; Islets of Langerhans; Klebsiella pneumoniae; Lipopolysaccharides; Lymphocyte Transfusion; Mice; Mice, Inbred NOD; Recombinant Proteins; Spleen | 1996 |
Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A.
Topics: Animals; Calcitriol; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Immunosuppressive Agents; Islets of Langerhans; Mice; Mice, Inbred NOD; Stereoisomerism | 1996 |
Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
Topics: Administration, Oral; Biological Availability; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Immunosuppressive Agents; Kidney Transplantation; Metabolic Clearance Rate | 1996 |
Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Flow Cytometry; Graft Rejection; Graft Survival; Immunosuppressive Agents; Islets of Langerhans Transplantation; Lymph Nodes; Lymphocyte Transfusion; Male; Rats; Rats, Inbred BB; Rats, Inbred BN; Rats, Inbred WF; T-Lymphocyte Subsets; T-Lymphocytes; Time Factors; Transplantation, Homologous | 1997 |
Islet transplantation in IDDM patients.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Survival; Humans; Immunosuppressive Agents; Insulin; Islets of Langerhans Transplantation; Kidney Transplantation; Male; Prednisolone | 1997 |
Ulcerating necrobiosis lipoidica resolving in response to cyclosporine-A.
Topics: Adult; Antirheumatic Agents; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Necrobiosis Lipoidica | 1997 |
Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Graft Survival; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Rats; Rats, Sprague-Dawley; Species Specificity; Transplantation, Heterologous | 1997 |
Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats.
Topics: Animals; Antibodies, Monoclonal; Autoimmunity; Blood Glucose; CD4 Antigens; CD4-Positive T-Lymphocytes; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Islets of Langerhans; Major Histocompatibility Complex; Rats; Rats, Inbred BB; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic | 1997 |
Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Graft Survival; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Swine; Transplantation, Heterologous | 1997 |
Reversal of hyperglycemia in diabetic NOD mice by human proinsulin gene therapy.
Topics: 3T3 Cells; Animals; Blood Glucose; Cell Transplantation; Cloning, Molecular; Cyclosporine; Diabetes Mellitus, Type 1; Female; Genetic Therapy; Humans; Immunosuppressive Agents; Insulin, Long-Acting; Liver; Mice; Mice, Inbred NOD; Proinsulin; Transfection; Transplantation, Homologous | 1997 |
Combined kidney-pancreas and parathyroid transplantation: a case report.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Follow-Up Studies; Glucocorticoids; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases, Cystic; Kidney Failure, Chronic; Kidney Medulla; Kidney Transplantation; Male; Pancreas Transplantation; Parathyroid Glands; Polyendocrinopathies, Autoimmune; Prednisone; Transplantation, Homologous | 1997 |
Long-term renal function in type I diabetics after kidney or kidney-pancreas transplantation: influence of number, timing, and treatment of acute rejection episodes.
Topics: Acute Disease; Adult; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Linear Models; Male; Middle Aged; Pancreas Transplantation; Time Factors | 1997 |
Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A.
Topics: Animals; Calcitriol; Calcium; Cyclosporine; Cytokines; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Immunosuppressive Agents; Mice; Mice, Inbred NOD; Osteocalcin; Polymerase Chain Reaction | 1998 |
Case report. Use of an argon laser to treat drug-induced gingival overgrowth.
Topics: Anticonvulsants; Argon; Calcium Channel Blockers; Candidiasis, Oral; Cyclosporine; Denture, Complete; Diabetes Mellitus, Type 1; Gingival Hyperplasia; Gingivectomy; Humans; Immunosuppressive Agents; Kidney Transplantation; Laser Therapy; Male; Middle Aged; Patient Education as Topic; Phenytoin | 1998 |
Improvement of glucose/insulin metabolism reduces hypertension in insulin-dependent diabetes mellitus recipients of kidney-pancreas transplantation.
Topics: Adult; Blood Glucose; Cause of Death; Chi-Square Distribution; Cohort Studies; Cyclosporine; Cystostomy; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Duodenostomy; Female; Follow-Up Studies; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Retrospective Studies | 1998 |
Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine.
Topics: Adult; Age Factors; Cholesterol; Cyclosporine; Diabetes Mellitus, Type 1; Female; Furosemide; Humans; Hypercholesterolemia; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Sex Factors; Tacrolimus | 1998 |
Pregnancy after pancreas transplantation in the cyclosporine era: report from the International Pancreas Transplant Registry.
Topics: Adult; Age of Onset; Birth Weight; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Immunosuppressive Agents; Infant, Newborn; International Cooperation; Kidney Transplantation; Pancreas Transplantation; Pregnancy; Pregnancy Outcome; Registries | 1998 |
Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression.
Topics: Adult; Cholesterol; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Pancreas Transplantation; Tacrolimus; Transplantation, Homologous | 1998 |
Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1,25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2.
Topics: Animals; Calcitriol; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Immunosuppressive Agents; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Recurrence; Th1 Cells; Th2 Cells; Transplantation, Isogeneic | 1998 |
Selective CellCept therapy in high-risk renal transplant recipients.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Prednisone; Reoperation; Retrospective Studies; Survival Rate | 1998 |
Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation.
Topics: Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus | 1998 |
Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Tacrolimus | 1998 |
Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.
Topics: Administration, Oral; Adolescent; Blood Glucose; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Emulsions; Follow-Up Studies; Humans; Hyperglycemia; Immunosuppressive Agents; Infant; Liver Transplantation; Male; Tacrolimus; Time Factors | 1998 |
Xenotransplantation of bovine islets into the thymus of totally pancreatectomized pigs.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Cattle; Cyclosporine; Diabetes Mellitus, Type 1; Electrolytes; Female; Graft Survival; Immunosuppressive Agents; Insulin; Islets of Langerhans Transplantation; Pancreatectomy; Swine; Thymus Gland; Time Factors; Transplantation, Heterologous; Transplantation, Heterotopic | 1998 |
Can we improve the results of simultaneous pancreas-kidney transplantation?
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Organ Preservation; Pancreas; Pancreas Transplantation; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 1998 |
Troglitazone, a new antidiabetic agent, decreases cyclosporine level.
Topics: Aged; Chromans; Cyclosporine; Diabetes Mellitus, Type 1; Drug Interactions; Heart Transplantation; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Male; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Cyclosporine disposition and long-term renal function in a 500-pound kidney transplant recipient.
Topics: Biological Availability; Cadaver; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Obesity, Morbid | 1998 |
Lipids increase after solitary pancreas transplantation.
Topics: Blood Pressure; Cholesterol; Cholesterol, HDL; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Pancreas Transplantation; Tacrolimus; Time Factors; Triglycerides | 1999 |
A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
Topics: Animals; Azathioprine; Cell Division; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; In Vitro Techniques; Islets of Langerhans Transplantation; Leukocytes, Mononuclear; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Methylprednisolone; Mycophenolic Acid; Phytohemagglutinins; Sirolimus; Species Specificity; Swine; Tacrolimus; Transplantation, Homologous | 1999 |
[Combined renal and pancreas transplantation as treatment for chronic renal insufficiency of diabetic origin: a series of 50 consecutive transplantations].
Topics: Adult; Azathioprine; Combined Modality Therapy; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Survival Analysis; Tacrolimus; Treatment Outcome | 1999 |
Long-term functional islet mass and metabolic function after xenoislet transplantation in primates.
Topics: Animals; CD3 Complex; Chlorocebus aethiops; Cyclosporine; Diabetes Mellitus, Type 1; Diphtheria Toxin; Fasting; Glucose Tolerance Test; Graft vs Host Disease; Immunoglobulin Fragments; Immunosuppressive Agents; Immunotoxins; Islets of Langerhans; Islets of Langerhans Transplantation; Macaca fascicularis; Macaca mulatta; Methylprednisolone; Organ Size; Recombinant Fusion Proteins; Transplantation, Heterologous | 2000 |
Sequential intraportal islet allografts in immunosuppressed type I diabetic patients: preliminary results.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Islets of Langerhans Transplantation; Male; Mycophenolic Acid; Portal System; Transplantation, Homologous | 2000 |
Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Nervous System Diseases; Retrospective Studies; Tacrolimus | 2000 |
Non-pseudomonal malignant otitis externa and jugular foramen syndrome secondary to cyclosporin-induced hypertrichosis in a diabetic renal transplant patient.
Topics: Candidiasis; Cyclosporine; Diabetes Mellitus, Type 1; Fatal Outcome; Humans; Hypertrichosis; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Otitis Externa; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Tomography, Emission-Computed, Single-Photon | 2000 |
Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient.
Topics: Adult; Clopidogrel; Coronary Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Plasmapheresis; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Ticlopidine | 2000 |
Successful conversion from cyclosporine to tacrolimus for immunosuppression.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppressive Agents; Inflammation; Insulin; Liver Function Tests; Liver Transplantation; Male; Neutrophils; Tacrolimus | 2000 |
Comparison of pancreas transplantation outcome between the cyclosporine and tacrolimus eras.
Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancreas Transplantation; Pancreatitis; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 2000 |
Cyclosporine challenge test revisited: does it predict outcome after solitary pancreas transplantation?
Topics: Adult; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppressive Agents; Male; Pancreas Transplantation; Postoperative Complications; Predictive Value of Tests; Renal Insufficiency | 2001 |
Breast-feeding by a cyclosporine-treated mother.
Topics: Adult; Breast Feeding; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Male; Milk, Human; Pancreas Transplantation; Postpartum Period; Pregnancy; Pregnancy Complications | 2001 |
Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
Topics: Alkynes; Animals; Cyclosporine; Diabetes Mellitus, Type 1; Drug Synergism; Graft Rejection; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mice; Mice, Inbred NOD; Nitriles; Rats; Transplantation, Heterologous | 2001 |
Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation.
Topics: Alkynes; Animals; Blood Glucose; Cholecalciferol; Cyclosporine; Diabetes Mellitus, Type 1; Graft Survival; Immunosuppression Therapy; Interferon-beta; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Recurrence; Stereoisomerism; Subrenal Capsule Assay; Transplantation, Isogeneic | 2001 |
A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice.
Topics: Animals; Calcitriol; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Immunosuppressive Agents; Male; Mice; Mice, Inbred NOD; Rats; Rats, Inbred BB; Time Factors; Transplantation, Heterologous | 2001 |
Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.
Topics: Adoptive Transfer; Adult; Animals; Autoantibodies; Autoimmune Diseases; Cell Transplantation; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Freund's Adjuvant; Glutamate Decarboxylase; Graft Enhancement, Immunologic; Graft Survival; H-2 Antigens; Humans; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Multicenter Studies as Topic; Nephrectomy; Niacinamide; Pancreatectomy; T-Lymphocytes | 2001 |
Postabsorptive muscle protein metabolism in type 1 diabetic patients after pancreas transplantation.
Topics: Adult; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Energy Intake; Forearm; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Insulin; Leucine; Middle Aged; Muscle Proteins; Muscle, Skeletal; Pancreas Transplantation; Phenylalanine; Prednisone; Protein Biosynthesis; Proteins; Reference Values; Regional Blood Flow | 2000 |
Improvement in hypertension in patients with diabetes mellitus after kidney/pancreas transplantation.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cyclosporine; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Female; Glycated Hemoglobin; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas; Pancreas Transplantation; Time Factors | 2001 |
[Focus on Islets of Langerhans transplantation].
Topics: Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Basiliximab; Clinical Protocols; Cyclosporine; Daclizumab; Diabetes Mellitus, Type 1; Everolimus; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Islets of Langerhans Transplantation; Prodrugs; Receptors, Interleukin-2; Recombinant Fusion Proteins; Sirolimus; Tacrolimus | 2001 |
Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
Topics: Animals; Anti-Bacterial Agents; Antirheumatic Agents; Arthritis; Cell Division; Collagen; Cyclosporine; Cytokines; Diabetes Mellitus, Type 1; Disease Progression; Female; Gene Expression Regulation; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nitrites; Prodigiosin; Receptors, Interleukin; Signal Transduction; T-Lymphocytes | 2001 |
Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Drug Tolerance; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Pancreas Transplantation; Retrospective Studies; Salvage Therapy; Survival Rate; Tacrolimus | 2002 |
Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.
Topics: Alkynes; Animals; Cholecalciferol; Combined Modality Therapy; Cyclosporine; Diabetes Mellitus, Type 1; Drug Synergism; Drug Therapy, Combination; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Recurrence | 2002 |
The effect of azathioprine, cyclosporine A and insulin on the in vitro lymphocyte-mediated cytotoxicity in type I diabetic patients.
Topics: Adolescent; Adult; Azathioprine; Child; Cyclosporine; Cytotoxicity, Immunologic; Diabetes Mellitus, Type 1; Female; HLA-DR Antigens; Humans; Insulin; Islets of Langerhans; Lymphocytes; Male; Pancreas; T-Lymphocytes | 1992 |
Cyclosporin A treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus. London Diabetes Study Group.
Topics: Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Infant; Male | 1992 |
Cyclosporin reduces renal prostanoid excretion in type 1 diabetic patients.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Exercise; Glycated Hemoglobin; Humans; Insulin; Kidney; Lactates; Male; Prostaglandins; Thromboxane A2 | 1992 |
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.
Topics: Adolescent; Adult; Age Factors; Autoimmune Diseases; Blood Pressure; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Psoriasis; Retrospective Studies; Risk Factors; Sjogren's Syndrome; Uveitis | 1992 |
Cyclosporine therapy for autoimmune disease.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Kidney Diseases; Psoriasis | 1992 |
Importance of cyclosporine dosage and blood levels in simultaneous pancreas and kidney transplant success.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Graft Rejection; Humans; Immunosuppression Therapy; Interleukin-2; Kidney Transplantation; Male; Methylprednisolone; Pancreas Transplantation; Receptors, Interleukin-2; Uremia | 1992 |
Is HLA matching worthwhile in pancreatic transplantation?
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Methylprednisolone; Pancreas Transplantation; Retrospective Studies; Time Factors; Treatment Outcome | 1992 |
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.
Topics: Adolescent; Child; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Male; Tacrolimus; Transplantation Immunology | 1991 |
[Clinical follow-up, histologic findings and therapeutic problems in a patient with bilateral ulcus rodens Mooren].
Topics: Adult; Cataract Extraction; Cornea; Corneal Opacity; Corneal Stroma; Corneal Ulcer; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Humans; Keratoplasty, Penetrating; Male; Ophthalmic Solutions; Postoperative Complications | 1991 |
Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Blood Glucose; C-Peptide; Cell Separation; Cells, Cultured; Cyclosporine; Diabetes Mellitus, Type 1; Histocompatibility Testing; Humans; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Kidney Transplantation; Monitoring, Physiologic; Prednisone; Tissue and Organ Procurement | 1991 |
The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type I diabetes mellitus.
Topics: Adolescent; Adult; Age Factors; Autoantibodies; Biomarkers; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Humans; Islets of Langerhans; Male; Receptors, Interleukin-2; Time Factors | 1991 |
Orthodontic therapy in the patient treated with cyclosporine.
Topics: Adolescent; Child; Cyclosporine; Dental Occlusion, Traumatic; Dental Plaque; Diabetes Mellitus, Type 1; Diastema; Female; Gingival Hyperplasia; Humans; Male; Orthodontic Appliances; Orthodontics, Corrective; Tooth, Unerupted | 1991 |
[Metabolic and immunologic effects of cyclosporine administration in new insulin-dependent diabetics].
Topics: Antibody Formation; Autoantibodies; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Immunity, Cellular; Insulin; Insulin Secretion; Islets of Langerhans | 1985 |
Ciclosporin treatment in experimental autoimmune myasthenia gravis.
Topics: Animals; Autoantibodies; Cyclosporine; Cyclosporins; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Myasthenia Gravis; Rats; Rats, Inbred BB; Rats, Inbred Lew | 1988 |